Why is Fischer Medical falling/rising?

As of 02-Sep, Fischer Medical Ventures Ltd is experiencing a price increase, currently at 1,065.90, reflecting a rise of 14.8 or 1.41%. The stock has recently hit a new 52-week high of Rs. 1094 and has outperformed its sector by 1.32%. It has shown consistent gains over the last two days, with a total return of 2.26% during this period. Over the past year, the stock has generated a remarkable return of 70.54%, significantly outperforming the BSE500 index. The company has reported strong financial results, including a 247.89% growth in net sales and a 160.70% increase in profit after tax, which are contributing positively to investor sentiment. However, it also faces challenges, such as a low return on equity of 1.39% and a high price-to-book value ratio of 22.5, indicating potential concerns about profitability and valuation.
In the broader market context, Fischer Medical's short-term performance stands in contrast to the benchmark, as it has gained 0.14% over the past week while the Sensex has declined by 0.78%. This divergence highlights the stock's resilience and attractiveness to investors, particularly given its strong recent performance and low debt levels. Despite the overall market challenges, Fischer Medical's significant growth metrics and consistent returns over the past three years suggest a favorable outlook, although the lack of domestic mutual fund investment may indicate some caution among institutional investors.